nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—CYP2C9—Diclofenamide—glaucoma	0.0969	0.242	CbGbCtD
Candesartan—CYP2C9—Dorzolamide—glaucoma	0.0936	0.233	CbGbCtD
Candesartan—CYP2C9—Methazolamide—glaucoma	0.0834	0.208	CbGbCtD
Candesartan—ABCB1—Timolol—glaucoma	0.0688	0.172	CbGbCtD
Candesartan—ABCB1—Clonidine—glaucoma	0.0585	0.146	CbGbCtD
Candesartan—AGTR1—ACE Inhibitor Pathway—MAS1—glaucoma	0.0106	0.0968	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—ACE2—glaucoma	0.00807	0.0734	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00426	0.0387	CbGpPWpGaD
Candesartan—Pranlukast—TNF—glaucoma	0.00328	1	CrCbGaD
Candesartan—UGT1A3—Estrogen metabolism—CYP1B1—glaucoma	0.00319	0.029	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.0029	0.0264	CbGpPWpGaD
Candesartan—UGT1A3—Estrogen metabolism—GSTM1—glaucoma	0.00255	0.0232	CbGpPWpGaD
Candesartan—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00254	0.0231	CbGpPWpGaD
Candesartan—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00222	0.0202	CbGpPWpGaD
Candesartan—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00202	0.0184	CbGpPWpGaD
Candesartan—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00181	0.0164	CbGpPWpGaD
Candesartan—AGTR1—ACE Inhibitor Pathway—NOS3—glaucoma	0.00178	0.0162	CbGpPWpGaD
Candesartan—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00164	0.0149	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00151	0.0137	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—OPN4—glaucoma	0.00143	0.013	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—PTGFR—glaucoma	0.00129	0.0117	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00128	0.0116	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00121	0.011	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—SLC6A13—glaucoma	0.00118	0.0107	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00115	0.0105	CbGpPWpGaD
Candesartan—UGT1A3—Phase II conjugation—GSTT1—glaucoma	0.00112	0.0102	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00111	0.0101	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.00107	0.0097	CbGpPWpGaD
Candesartan—CYP2C8—Tamoxifen metabolism—CYP1B1—glaucoma	0.00103	0.00933	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000996	0.00905	CbGpPWpGaD
Candesartan—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.00099	0.009	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TXN—glaucoma	0.000967	0.00879	CbGpPWpGaD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000965	0.00878	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000947	0.00861	CbGpPWpGaD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.000943	0.00858	CbGpPWpGaD
Candesartan—Acute coronary syndrome—Betaxolol—glaucoma	0.000896	0.00184	CcSEcCtD
Candesartan—Cough—Pilocarpine—glaucoma	0.000891	0.00184	CcSEcCtD
Candesartan—Myocardial infarction—Betaxolol—glaucoma	0.000891	0.00183	CcSEcCtD
Candesartan—Dizziness—Latanoprost—glaucoma	0.00089	0.00183	CcSEcCtD
Candesartan—Vomiting—Methazolamide—glaucoma	0.000884	0.00182	CcSEcCtD
Candesartan—Hypertension—Pilocarpine—glaucoma	0.000882	0.00182	CcSEcCtD
Candesartan—Gastrointestinal pain—Apraclonidine—glaucoma	0.00088	0.00181	CcSEcCtD
Candesartan—Rash—Methazolamide—glaucoma	0.000877	0.00181	CcSEcCtD
Candesartan—Dermatitis—Methazolamide—glaucoma	0.000876	0.0018	CcSEcCtD
Candesartan—Nausea—Carbachol—glaucoma	0.000875	0.0018	CcSEcCtD
Candesartan—Headache—Methazolamide—glaucoma	0.000871	0.00179	CcSEcCtD
Candesartan—Chest pain—Pilocarpine—glaucoma	0.00087	0.00179	CcSEcCtD
Candesartan—Arthralgia—Pilocarpine—glaucoma	0.00087	0.00179	CcSEcCtD
Candesartan—Myalgia—Pilocarpine—glaucoma	0.00087	0.00179	CcSEcCtD
Candesartan—Anxiety—Pilocarpine—glaucoma	0.000866	0.00178	CcSEcCtD
Candesartan—Paraesthesia—Acetazolamide—glaucoma	0.000864	0.00178	CcSEcCtD
Candesartan—Hypotension—Brimonidine—glaucoma	0.000863	0.00178	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—SLC6A1—glaucoma	0.000862	0.00784	CbGpPWpGaD
Candesartan—Nausea—Levobunolol—glaucoma	0.000862	0.00178	CcSEcCtD
Candesartan—Tachycardia—Travoprost—glaucoma	0.000857	0.00177	CcSEcCtD
Candesartan—Epistaxis—Betaxolol—glaucoma	0.000857	0.00176	CcSEcCtD
Candesartan—Somnolence—Acetazolamide—glaucoma	0.000856	0.00176	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000853	0.00776	CbGpPWpGaD
Candesartan—Hyperhidrosis—Dorzolamide—glaucoma	0.000853	0.00176	CcSEcCtD
Candesartan—Sinusitis—Betaxolol—glaucoma	0.000852	0.00176	CcSEcCtD
Candesartan—Abdominal pain—Apraclonidine—glaucoma	0.000851	0.00175	CcSEcCtD
Candesartan—Rash—Latanoprost—glaucoma	0.000849	0.00175	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL1A—glaucoma	0.000848	0.00771	CbGpPWpGaD
Candesartan—Agranulocytosis—Betaxolol—glaucoma	0.000848	0.00175	CcSEcCtD
Candesartan—Dermatitis—Latanoprost—glaucoma	0.000848	0.00175	CcSEcCtD
Candesartan—Dyspepsia—Acetazolamide—glaucoma	0.000847	0.00174	CcSEcCtD
Candesartan—Tachycardia—Brinzolamide—glaucoma	0.000846	0.00174	CcSEcCtD
Candesartan—Headache—Latanoprost—glaucoma	0.000843	0.00174	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000842	0.00173	CcSEcCtD
Candesartan—CYP2C9—Tamoxifen metabolism—CYP1B1—glaucoma	0.000835	0.00759	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000831	0.00171	CcSEcCtD
Candesartan—Fatigue—Acetazolamide—glaucoma	0.00083	0.00171	CcSEcCtD
Candesartan—Paraesthesia—Brimonidine—glaucoma	0.000829	0.00171	CcSEcCtD
Candesartan—Nausea—Methazolamide—glaucoma	0.000826	0.0017	CcSEcCtD
Candesartan—Hypotension—Dorzolamide—glaucoma	0.000824	0.0017	CcSEcCtD
Candesartan—Dyspnoea—Brimonidine—glaucoma	0.000823	0.0017	CcSEcCtD
Candesartan—Somnolence—Brimonidine—glaucoma	0.000821	0.00169	CcSEcCtD
Candesartan—Mental disorder—Clonidine—glaucoma	0.000821	0.00169	CcSEcCtD
Candesartan—Hypotension—Travoprost—glaucoma	0.000821	0.00169	CcSEcCtD
Candesartan—Rhinitis—Betaxolol—glaucoma	0.000818	0.00168	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000817	0.00743	CbGpPWpGaD
Candesartan—Thrombocytopenia—Pilocarpine—glaucoma	0.000816	0.00168	CcSEcCtD
Candesartan—Tachycardia—Pilocarpine—glaucoma	0.000814	0.00168	CcSEcCtD
Candesartan—Dyspepsia—Brimonidine—glaucoma	0.000813	0.00167	CcSEcCtD
Candesartan—Angina pectoris—Timolol—glaucoma	0.000811	0.00167	CcSEcCtD
Candesartan—Hypotension—Brinzolamide—glaucoma	0.00081	0.00167	CcSEcCtD
Candesartan—Pharyngitis—Betaxolol—glaucoma	0.00081	0.00167	CcSEcCtD
Candesartan—Hyperhidrosis—Pilocarpine—glaucoma	0.000806	0.00166	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000804	0.00166	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Travoprost—glaucoma	0.0008	0.00165	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.0008	0.00727	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Brimonidine—glaucoma	0.000797	0.00164	CcSEcCtD
Candesartan—Fatigue—Brimonidine—glaucoma	0.000796	0.00164	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000793	0.00721	CbGpPWpGaD
Candesartan—Paraesthesia—Dorzolamide—glaucoma	0.000792	0.00163	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00079	0.00163	CcSEcCtD
Candesartan—Dyspnoea—Dorzolamide—glaucoma	0.000786	0.00162	CcSEcCtD
Candesartan—Somnolence—Dorzolamide—glaucoma	0.000784	0.00161	CcSEcCtD
Candesartan—Dyspnoea—Travoprost—glaucoma	0.000783	0.00161	CcSEcCtD
Candesartan—Hypotension—Pilocarpine—glaucoma	0.000779	0.0016	CcSEcCtD
Candesartan—Paraesthesia—Brinzolamide—glaucoma	0.000779	0.0016	CcSEcCtD
Candesartan—Dyspepsia—Dorzolamide—glaucoma	0.000776	0.0016	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000775	0.00705	CbGpPWpGaD
Candesartan—Upper respiratory tract infection—Timolol—glaucoma	0.000774	0.00159	CcSEcCtD
Candesartan—Dyspnoea—Brinzolamide—glaucoma	0.000773	0.00159	CcSEcCtD
Candesartan—Dyspepsia—Travoprost—glaucoma	0.000773	0.00159	CcSEcCtD
Candesartan—Asthenia—Apraclonidine—glaucoma	0.000772	0.00159	CcSEcCtD
Candesartan—Somnolence—Brinzolamide—glaucoma	0.000771	0.00159	CcSEcCtD
Candesartan—Urticaria—Acetazolamide—glaucoma	0.000765	0.00157	CcSEcCtD
Candesartan—Dyspepsia—Brinzolamide—glaucoma	0.000763	0.00157	CcSEcCtD
Candesartan—Pruritus—Apraclonidine—glaucoma	0.000761	0.00157	CcSEcCtD
Candesartan—Body temperature increased—Acetazolamide—glaucoma	0.000761	0.00157	CcSEcCtD
Candesartan—Fatigue—Dorzolamide—glaucoma	0.000761	0.00157	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000759	0.00156	CcSEcCtD
Candesartan—Gastrointestinal disorder—Travoprost—glaucoma	0.000758	0.00156	CcSEcCtD
Candesartan—Fatigue—Travoprost—glaucoma	0.000757	0.00156	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—FAS—glaucoma	0.000756	0.00687	CbGpPWpGaD
Candesartan—Hyperglycaemia—Timolol—glaucoma	0.000751	0.00155	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.000749	0.00681	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000749	0.00154	CcSEcCtD
Candesartan—Paraesthesia—Pilocarpine—glaucoma	0.000748	0.00154	CcSEcCtD
Candesartan—Asthenia—Bimatoprost—glaucoma	0.000748	0.00154	CcSEcCtD
Candesartan—Fatigue—Brinzolamide—glaucoma	0.000748	0.00154	CcSEcCtD
Candesartan—Angioedema—Clonidine—glaucoma	0.000745	0.00153	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—C3—glaucoma	0.000745	0.00678	CbGpPWpGaD
Candesartan—Dyspnoea—Pilocarpine—glaucoma	0.000743	0.00153	CcSEcCtD
Candesartan—Somnolence—Pilocarpine—glaucoma	0.000741	0.00153	CcSEcCtD
Candesartan—Pruritus—Bimatoprost—glaucoma	0.000738	0.00152	CcSEcCtD
Candesartan—Diarrhoea—Apraclonidine—glaucoma	0.000736	0.00152	CcSEcCtD
Candesartan—Dyspepsia—Pilocarpine—glaucoma	0.000734	0.00151	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—OPN4—glaucoma	0.000721	0.00656	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Dorzolamide—glaucoma	0.000721	0.00149	CcSEcCtD
Candesartan—Palpitations—Clonidine—glaucoma	0.000721	0.00148	CcSEcCtD
Candesartan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00072	0.00148	CcSEcCtD
Candesartan—Gastrointestinal pain—Travoprost—glaucoma	0.000718	0.00148	CcSEcCtD
Candesartan—UGT1A3—Phase II conjugation—GSTM1—glaucoma	0.000716	0.00651	CbGpPWpGaD
Candesartan—Mental disorder—Betaxolol—glaucoma	0.000715	0.00147	CcSEcCtD
Candesartan—Cough—Clonidine—glaucoma	0.000712	0.00147	CcSEcCtD
Candesartan—Dizziness—Apraclonidine—glaucoma	0.000711	0.00147	CcSEcCtD
Candesartan—Malnutrition—Betaxolol—glaucoma	0.00071	0.00146	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—TGFB2—glaucoma	0.000703	0.00639	CbGpPWpGaD
Candesartan—Urticaria—Dorzolamide—glaucoma	0.000701	0.00144	CcSEcCtD
Candesartan—Epistaxis—Timolol—glaucoma	0.0007	0.00144	CcSEcCtD
Candesartan—Abdominal pain—Dorzolamide—glaucoma	0.000697	0.00144	CcSEcCtD
Candesartan—Body temperature increased—Dorzolamide—glaucoma	0.000697	0.00144	CcSEcCtD
Candesartan—Sinusitis—Timolol—glaucoma	0.000696	0.00143	CcSEcCtD
Candesartan—Arthralgia—Clonidine—glaucoma	0.000694	0.00143	CcSEcCtD
Candesartan—Chest pain—Clonidine—glaucoma	0.000694	0.00143	CcSEcCtD
Candesartan—Abdominal pain—Travoprost—glaucoma	0.000694	0.00143	CcSEcCtD
Candesartan—Agranulocytosis—Timolol—glaucoma	0.000693	0.00143	CcSEcCtD
Candesartan—Anxiety—Clonidine—glaucoma	0.000692	0.00142	CcSEcCtD
Candesartan—Asthenia—Acetazolamide—glaucoma	0.00069	0.00142	CcSEcCtD
Candesartan—Dizziness—Bimatoprost—glaucoma	0.00069	0.00142	CcSEcCtD
Candesartan—Urticaria—Brinzolamide—glaucoma	0.000689	0.00142	CcSEcCtD
Candesartan—Vomiting—Apraclonidine—glaucoma	0.000684	0.00141	CcSEcCtD
Candesartan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000682	0.0014	CcSEcCtD
Candesartan—Dermatitis—Apraclonidine—glaucoma	0.000678	0.0014	CcSEcCtD
Candesartan—Headache—Apraclonidine—glaucoma	0.000674	0.00139	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000668	0.00608	CbGpPWpGaD
Candesartan—Rhinitis—Timolol—glaucoma	0.000668	0.00138	CcSEcCtD
Candesartan—Asthenia—Brimonidine—glaucoma	0.000663	0.00136	CcSEcCtD
Candesartan—Abdominal pain—Pilocarpine—glaucoma	0.000659	0.00136	CcSEcCtD
Candesartan—Body temperature increased—Pilocarpine—glaucoma	0.000659	0.00136	CcSEcCtD
Candesartan—Diarrhoea—Acetazolamide—glaucoma	0.000658	0.00136	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—GSTT1—glaucoma	0.000658	0.00598	CbGpPWpGaD
Candesartan—Rash—Bimatoprost—glaucoma	0.000658	0.00135	CcSEcCtD
Candesartan—Dermatitis—Bimatoprost—glaucoma	0.000657	0.00135	CcSEcCtD
Candesartan—Oedema peripheral—Timolol—glaucoma	0.000656	0.00135	CcSEcCtD
Candesartan—Anaemia—Betaxolol—glaucoma	0.000656	0.00135	CcSEcCtD
Candesartan—Pruritus—Brimonidine—glaucoma	0.000653	0.00135	CcSEcCtD
Candesartan—Headache—Bimatoprost—glaucoma	0.000653	0.00135	CcSEcCtD
Candesartan—Thrombocytopenia—Clonidine—glaucoma	0.000652	0.00134	CcSEcCtD
Candesartan—Tachycardia—Clonidine—glaucoma	0.00065	0.00134	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—PTGFR—glaucoma	0.00065	0.00591	CbGpPWpGaD
Candesartan—Hyperhidrosis—Clonidine—glaucoma	0.000643	0.00133	CcSEcCtD
Candesartan—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000643	0.00585	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000643	0.00584	CbGpPWpGaD
Candesartan—Nausea—Apraclonidine—glaucoma	0.000639	0.00132	CcSEcCtD
Candesartan—Vertigo—Betaxolol—glaucoma	0.000638	0.00131	CcSEcCtD
Candesartan—Dizziness—Acetazolamide—glaucoma	0.000636	0.00131	CcSEcCtD
Candesartan—Asthenia—Dorzolamide—glaucoma	0.000633	0.0013	CcSEcCtD
Candesartan—Asthenia—Travoprost—glaucoma	0.00063	0.0013	CcSEcCtD
Candesartan—Palpitations—Betaxolol—glaucoma	0.000627	0.00129	CcSEcCtD
Candesartan—Pruritus—Dorzolamide—glaucoma	0.000624	0.00129	CcSEcCtD
Candesartan—Asthenia—Brinzolamide—glaucoma	0.000622	0.00128	CcSEcCtD
Candesartan—Hypotension—Clonidine—glaucoma	0.000622	0.00128	CcSEcCtD
Candesartan—Pruritus—Travoprost—glaucoma	0.000621	0.00128	CcSEcCtD
Candesartan—Cough—Betaxolol—glaucoma	0.00062	0.00128	CcSEcCtD
Candesartan—Nausea—Bimatoprost—glaucoma	0.00062	0.00128	CcSEcCtD
Candesartan—Pruritus—Brinzolamide—glaucoma	0.000614	0.00126	CcSEcCtD
Candesartan—Vomiting—Acetazolamide—glaucoma	0.000612	0.00126	CcSEcCtD
Candesartan—Dizziness—Brimonidine—glaucoma	0.000611	0.00126	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000608	0.00553	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000606	0.00125	CcSEcCtD
Candesartan—Chest pain—Betaxolol—glaucoma	0.000605	0.00124	CcSEcCtD
Candesartan—Myalgia—Betaxolol—glaucoma	0.000605	0.00124	CcSEcCtD
Candesartan—Arthralgia—Betaxolol—glaucoma	0.000605	0.00124	CcSEcCtD
Candesartan—Diarrhoea—Dorzolamide—glaucoma	0.000604	0.00124	CcSEcCtD
Candesartan—Headache—Acetazolamide—glaucoma	0.000603	0.00124	CcSEcCtD
Candesartan—Anxiety—Betaxolol—glaucoma	0.000602	0.00124	CcSEcCtD
Candesartan—Diarrhoea—Travoprost—glaucoma	0.000601	0.00124	CcSEcCtD
Candesartan—Asthenia—Pilocarpine—glaucoma	0.000598	0.00123	CcSEcCtD
Candesartan—Paraesthesia—Clonidine—glaucoma	0.000598	0.00123	CcSEcCtD
Candesartan—Dyspnoea—Clonidine—glaucoma	0.000593	0.00122	CcSEcCtD
Candesartan—Diarrhoea—Brinzolamide—glaucoma	0.000593	0.00122	CcSEcCtD
Candesartan—Somnolence—Clonidine—glaucoma	0.000592	0.00122	CcSEcCtD
Candesartan—Pruritus—Pilocarpine—glaucoma	0.00059	0.00121	CcSEcCtD
Candesartan—Mental disorder—Timolol—glaucoma	0.000584	0.0012	CcSEcCtD
Candesartan—Dizziness—Dorzolamide—glaucoma	0.000583	0.0012	CcSEcCtD
Candesartan—Rash—Brimonidine—glaucoma	0.000582	0.0012	CcSEcCtD
Candesartan—Dermatitis—Brimonidine—glaucoma	0.000582	0.0012	CcSEcCtD
Candesartan—Dizziness—Travoprost—glaucoma	0.000581	0.0012	CcSEcCtD
Candesartan—Malnutrition—Timolol—glaucoma	0.00058	0.00119	CcSEcCtD
Candesartan—Headache—Brimonidine—glaucoma	0.000579	0.00119	CcSEcCtD
Candesartan—Gastrointestinal disorder—Clonidine—glaucoma	0.000575	0.00118	CcSEcCtD
Candesartan—Fatigue—Clonidine—glaucoma	0.000574	0.00118	CcSEcCtD
Candesartan—Dizziness—Brinzolamide—glaucoma	0.000573	0.00118	CcSEcCtD
Candesartan—Nausea—Acetazolamide—glaucoma	0.000572	0.00118	CcSEcCtD
Candesartan—Diarrhoea—Pilocarpine—glaucoma	0.00057	0.00117	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000568	0.00516	CbGpPWpGaD
Candesartan—Thrombocytopenia—Betaxolol—glaucoma	0.000567	0.00117	CcSEcCtD
Candesartan—Tachycardia—Betaxolol—glaucoma	0.000566	0.00116	CcSEcCtD
Candesartan—Vomiting—Dorzolamide—glaucoma	0.000561	0.00116	CcSEcCtD
Candesartan—Hyperhidrosis—Betaxolol—glaucoma	0.00056	0.00115	CcSEcCtD
Candesartan—Rash—Dorzolamide—glaucoma	0.000556	0.00115	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000556	0.00505	CbGpPWpGaD
Candesartan—Dermatitis—Dorzolamide—glaucoma	0.000556	0.00114	CcSEcCtD
Candesartan—Rash—Travoprost—glaucoma	0.000554	0.00114	CcSEcCtD
Candesartan—Dermatitis—Travoprost—glaucoma	0.000553	0.00114	CcSEcCtD
Candesartan—Headache—Dorzolamide—glaucoma	0.000553	0.00114	CcSEcCtD
Candesartan—Vomiting—Brinzolamide—glaucoma	0.000551	0.00114	CcSEcCtD
Candesartan—Dizziness—Pilocarpine—glaucoma	0.000551	0.00114	CcSEcCtD
Candesartan—Headache—Travoprost—glaucoma	0.00055	0.00113	CcSEcCtD
Candesartan—Nausea—Brimonidine—glaucoma	0.000549	0.00113	CcSEcCtD
Candesartan—Rash—Brinzolamide—glaucoma	0.000547	0.00113	CcSEcCtD
Candesartan—Dermatitis—Brinzolamide—glaucoma	0.000546	0.00113	CcSEcCtD
Candesartan—Gastrointestinal pain—Clonidine—glaucoma	0.000544	0.00112	CcSEcCtD
Candesartan—Headache—Brinzolamide—glaucoma	0.000543	0.00112	CcSEcCtD
Candesartan—Hypotension—Betaxolol—glaucoma	0.000542	0.00112	CcSEcCtD
Candesartan—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000538	0.00489	CbGpPWpGaD
Candesartan—Angioedema—Timolol—glaucoma	0.00053	0.00109	CcSEcCtD
Candesartan—Vomiting—Pilocarpine—glaucoma	0.00053	0.00109	CcSEcCtD
Candesartan—Urticaria—Clonidine—glaucoma	0.000529	0.00109	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000528	0.00109	CcSEcCtD
Candesartan—Body temperature increased—Clonidine—glaucoma	0.000526	0.00108	CcSEcCtD
Candesartan—Abdominal pain—Clonidine—glaucoma	0.000526	0.00108	CcSEcCtD
Candesartan—Rash—Pilocarpine—glaucoma	0.000526	0.00108	CcSEcCtD
Candesartan—Dermatitis—Pilocarpine—glaucoma	0.000525	0.00108	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—CYP1B1—glaucoma	0.000524	0.00477	CbGpPWpGaD
Candesartan—Nausea—Dorzolamide—glaucoma	0.000524	0.00108	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000523	0.00476	CbGpPWpGaD
Candesartan—Headache—Pilocarpine—glaucoma	0.000522	0.00108	CcSEcCtD
Candesartan—Nausea—Travoprost—glaucoma	0.000522	0.00107	CcSEcCtD
Candesartan—Vertigo—Timolol—glaucoma	0.000521	0.00107	CcSEcCtD
Candesartan—Paraesthesia—Betaxolol—glaucoma	0.00052	0.00107	CcSEcCtD
Candesartan—UGT1A3—Metapathway biotransformation—CYP1B1—glaucoma	0.000517	0.0047	CbGpPWpGaD
Candesartan—Dyspnoea—Betaxolol—glaucoma	0.000517	0.00106	CcSEcCtD
Candesartan—Nausea—Brinzolamide—glaucoma	0.000515	0.00106	CcSEcCtD
Candesartan—Palpitations—Timolol—glaucoma	0.000513	0.00106	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000512	0.00466	CbGpPWpGaD
Candesartan—Dyspepsia—Betaxolol—glaucoma	0.00051	0.00105	CcSEcCtD
Candesartan—Cough—Timolol—glaucoma	0.000506	0.00104	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000505	0.00459	CbGpPWpGaD
Candesartan—Hypertension—Timolol—glaucoma	0.000501	0.00103	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betaxolol—glaucoma	0.0005	0.00103	CcSEcCtD
Candesartan—Fatigue—Betaxolol—glaucoma	0.0005	0.00103	CcSEcCtD
Candesartan—Nausea—Pilocarpine—glaucoma	0.000495	0.00102	CcSEcCtD
Candesartan—Arthralgia—Timolol—glaucoma	0.000494	0.00102	CcSEcCtD
Candesartan—Chest pain—Timolol—glaucoma	0.000494	0.00102	CcSEcCtD
Candesartan—Myalgia—Timolol—glaucoma	0.000494	0.00102	CcSEcCtD
Candesartan—Anxiety—Timolol—glaucoma	0.000492	0.00101	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—GSTM1—glaucoma	0.000478	0.00434	CbGpPWpGaD
Candesartan—Asthenia—Clonidine—glaucoma	0.000478	0.000983	CcSEcCtD
Candesartan—Pruritus—Clonidine—glaucoma	0.000471	0.00097	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.000463	0.00421	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CA5A—glaucoma	0.000461	0.00419	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NARFL—glaucoma	0.000461	0.00419	CbGpPWpGaD
Candesartan—Urticaria—Betaxolol—glaucoma	0.00046	0.000948	CcSEcCtD
Candesartan—Body temperature increased—Betaxolol—glaucoma	0.000458	0.000943	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000458	0.00416	CbGpPWpGaD
Candesartan—Hyperhidrosis—Timolol—glaucoma	0.000458	0.000942	CcSEcCtD
Candesartan—Diarrhoea—Clonidine—glaucoma	0.000455	0.000938	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.00045	0.00409	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000443	0.00403	CbGpPWpGaD
Candesartan—Hypotension—Timolol—glaucoma	0.000442	0.000911	CcSEcCtD
Candesartan—Dizziness—Clonidine—glaucoma	0.00044	0.000906	CcSEcCtD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000437	0.00397	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Timolol—glaucoma	0.000431	0.000888	CcSEcCtD
Candesartan—AGTR1—G alpha (q) signalling events—EDN1—glaucoma	0.000428	0.00389	CbGpPWpGaD
Candesartan—Paraesthesia—Timolol—glaucoma	0.000425	0.000875	CcSEcCtD
Candesartan—Vomiting—Clonidine—glaucoma	0.000423	0.000872	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.000423	0.00384	CbGpPWpGaD
Candesartan—Dyspnoea—Timolol—glaucoma	0.000422	0.000869	CcSEcCtD
Candesartan—Somnolence—Timolol—glaucoma	0.000421	0.000867	CcSEcCtD
Candesartan—Rash—Clonidine—glaucoma	0.00042	0.000864	CcSEcCtD
Candesartan—Dermatitis—Clonidine—glaucoma	0.000419	0.000863	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—GSTM1—glaucoma	0.000419	0.00381	CbGpPWpGaD
Candesartan—Headache—Clonidine—glaucoma	0.000417	0.000859	CcSEcCtD
Candesartan—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000417	0.00379	CbGpPWpGaD
Candesartan—Dyspepsia—Timolol—glaucoma	0.000417	0.000858	CcSEcCtD
Candesartan—Asthenia—Betaxolol—glaucoma	0.000416	0.000856	CcSEcCtD
Candesartan—UGT1A3—Metapathway biotransformation—GSTM1—glaucoma	0.000413	0.00376	CbGpPWpGaD
Candesartan—Pruritus—Betaxolol—glaucoma	0.00041	0.000844	CcSEcCtD
Candesartan—Gastrointestinal disorder—Timolol—glaucoma	0.000409	0.000842	CcSEcCtD
Candesartan—Fatigue—Timolol—glaucoma	0.000408	0.000841	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—OPN4—glaucoma	0.000408	0.00371	CbGpPWpGaD
Candesartan—Diarrhoea—Betaxolol—glaucoma	0.000397	0.000817	CcSEcCtD
Candesartan—Nausea—Clonidine—glaucoma	0.000395	0.000814	CcSEcCtD
Candesartan—Gastrointestinal pain—Timolol—glaucoma	0.000387	0.000797	CcSEcCtD
Candesartan—Dizziness—Betaxolol—glaucoma	0.000383	0.000789	CcSEcCtD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000383	0.00348	CbGpPWpGaD
Candesartan—Urticaria—Timolol—glaucoma	0.000376	0.000775	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—VEGFA—glaucoma	0.000374	0.0034	CbGpPWpGaD
Candesartan—Abdominal pain—Timolol—glaucoma	0.000374	0.000771	CcSEcCtD
Candesartan—Body temperature increased—Timolol—glaucoma	0.000374	0.000771	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000371	0.00337	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—OPN4—glaucoma	0.00037	0.00337	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—C3—glaucoma	0.000369	0.00336	CbGpPWpGaD
Candesartan—Vomiting—Betaxolol—glaucoma	0.000368	0.000759	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—PTGFR—glaucoma	0.000367	0.00334	CbGpPWpGaD
Candesartan—Rash—Betaxolol—glaucoma	0.000365	0.000752	CcSEcCtD
Candesartan—Dermatitis—Betaxolol—glaucoma	0.000365	0.000752	CcSEcCtD
Candesartan—Headache—Betaxolol—glaucoma	0.000363	0.000748	CcSEcCtD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00036	0.00328	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000359	0.00326	CbGpPWpGaD
Candesartan—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000357	0.00325	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000357	0.00324	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000356	0.00323	CbGpPWpGaD
Candesartan—Nausea—Betaxolol—glaucoma	0.000344	0.000709	CcSEcCtD
Candesartan—Asthenia—Timolol—glaucoma	0.00034	0.000699	CcSEcCtD
Candesartan—Pruritus—Timolol—glaucoma	0.000335	0.00069	CcSEcCtD
Candesartan—AGTR1—Signaling by GPCR—PTGFR—glaucoma	0.000333	0.00303	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—SMO—glaucoma	0.000328	0.00298	CbGpPWpGaD
Candesartan—Diarrhoea—Timolol—glaucoma	0.000324	0.000667	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TNF—glaucoma	0.000321	0.00292	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LRP12—glaucoma	0.000316	0.00287	CbGpPWpGaD
Candesartan—Dizziness—Timolol—glaucoma	0.000313	0.000645	CcSEcCtD
Candesartan—Vomiting—Timolol—glaucoma	0.000301	0.00062	CcSEcCtD
Candesartan—Rash—Timolol—glaucoma	0.000299	0.000615	CcSEcCtD
Candesartan—Dermatitis—Timolol—glaucoma	0.000298	0.000614	CcSEcCtD
Candesartan—Headache—Timolol—glaucoma	0.000297	0.000611	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—CYP1B1—glaucoma	0.000295	0.00268	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000292	0.00266	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.000289	0.00263	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000284	0.00258	CbGpPWpGaD
Candesartan—Nausea—Timolol—glaucoma	0.000281	0.000579	CcSEcCtD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000276	0.00251	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000265	0.00241	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA5A—glaucoma	0.00026	0.00236	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NARFL—glaucoma	0.00026	0.00236	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000249	0.00226	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000248	0.00225	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTT1—glaucoma	0.000239	0.00218	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—GSTM1—glaucoma	0.000236	0.00215	CbGpPWpGaD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.000231	0.0021	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	0.000227	0.00207	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CA1—glaucoma	0.000225	0.00205	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—FAS—glaucoma	0.000222	0.00202	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—C3—glaucoma	0.000219	0.00199	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—OPN4—glaucoma	0.000219	0.00199	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CTSA—glaucoma	0.000218	0.00198	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—EDN1—glaucoma	0.000216	0.00196	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CA2—glaucoma	0.000206	0.00187	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HEYL—glaucoma	0.000203	0.00185	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTGFR—glaucoma	0.000197	0.00179	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTT1—glaucoma	0.000195	0.00177	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000194	0.00176	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP1B1—glaucoma	0.000191	0.00173	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—C3—glaucoma	0.000189	0.00172	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	0.000188	0.00171	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	0.000188	0.00171	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000187	0.0017	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000179	0.00163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000178	0.00162	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—SMO—glaucoma	0.000168	0.00153	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NARFL—glaucoma	0.000168	0.00153	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA5A—glaucoma	0.000168	0.00153	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1B1—glaucoma	0.000155	0.00141	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RPTOR—glaucoma	0.000154	0.0014	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	0.000154	0.0014	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	0.000153	0.00139	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTM1—glaucoma	0.000152	0.00139	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	0.00015	0.00137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NCK2—glaucoma	0.000149	0.00136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA5A—glaucoma	0.000146	0.00133	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NARFL—glaucoma	0.000146	0.00133	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TXN—glaucoma	0.000145	0.00132	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000145	0.00132	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00014	0.00127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA5A—glaucoma	0.000137	0.00124	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NARFL—glaucoma	0.000137	0.00124	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000129	0.00117	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000128	0.00116	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000127	0.00115	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HDAC9—glaucoma	0.000127	0.00115	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA1—glaucoma	0.000127	0.00115	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTM1—glaucoma	0.000124	0.00113	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CTSA—glaucoma	0.000123	0.00112	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	0.000122	0.00111	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—EDN1—glaucoma	0.000122	0.00111	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00012	0.00109	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CA2—glaucoma	0.000116	0.00105	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000113	0.00103	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000113	0.00103	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTT1—glaucoma	0.000112	0.00102	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EDN1—glaucoma	0.000111	0.00101	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—glaucoma	0.00011	0.000999	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000109	0.000995	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—C3—glaucoma	0.000107	0.000969	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SMO—glaucoma	9.93e-05	0.000903	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—C3—glaucoma	9.68e-05	0.00088	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—glaucoma	9.42e-05	0.000856	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	9.36e-05	0.000851	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NTRK2—glaucoma	9.08e-05	0.000826	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1B1—glaucoma	8.96e-05	0.000815	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCA1—glaucoma	8.96e-05	0.000815	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.75e-05	0.000796	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA1—glaucoma	8.19e-05	0.000745	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TXN—glaucoma	8.17e-05	0.000743	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CTSA—glaucoma	7.93e-05	0.000721	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGFR—glaucoma	7.79e-05	0.000708	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA2—glaucoma	7.49e-05	0.000681	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.46e-05	0.000678	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NTRK1—glaucoma	7.4e-05	0.000673	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.39e-05	0.000672	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.32e-05	0.000666	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.32e-05	0.000666	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—glaucoma	7.17e-05	0.000652	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA1—glaucoma	7.14e-05	0.000649	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CTSA—glaucoma	6.91e-05	0.000628	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.89e-05	0.000626	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN2B—glaucoma	6.82e-05	0.00062	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA1—glaucoma	6.67e-05	0.000606	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EDN1—glaucoma	6.55e-05	0.000595	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA2—glaucoma	6.53e-05	0.000593	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.52e-05	0.000593	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CTSA—glaucoma	6.46e-05	0.000587	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTT1—glaucoma	6.34e-05	0.000576	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—glaucoma	6.33e-05	0.000576	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA2—glaucoma	6.1e-05	0.000554	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGF—glaucoma	6.02e-05	0.000547	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.96e-05	0.000542	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.96e-05	0.000542	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—glaucoma	5.9e-05	0.000536	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAV1—glaucoma	5.84e-05	0.000531	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—C3—glaucoma	5.72e-05	0.00052	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.42e-05	0.000493	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—glaucoma	5.32e-05	0.000484	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TXN—glaucoma	5.28e-05	0.00048	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CAV1—glaucoma	5.27e-05	0.00048	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.11e-05	0.000465	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCA1—glaucoma	5.05e-05	0.000459	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1B1—glaucoma	5.05e-05	0.000459	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FN1—glaucoma	5.02e-05	0.000457	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BAD—glaucoma	4.96e-05	0.000451	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.82e-05	0.000438	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.77e-05	0.000434	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.65e-05	0.000423	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TXN—glaucoma	4.6e-05	0.000418	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—glaucoma	4.42e-05	0.000402	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TXN—glaucoma	4.3e-05	0.000391	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.1e-05	0.000373	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—glaucoma	4.09e-05	0.000372	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—glaucoma	4.04e-05	0.000367	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—glaucoma	4.04e-05	0.000367	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—glaucoma	3.99e-05	0.000363	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.92e-05	0.000356	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.88e-05	0.000353	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—glaucoma	3.57e-05	0.000324	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—glaucoma	3.57e-05	0.000324	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—glaucoma	3.46e-05	0.000314	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—glaucoma	3.33e-05	0.000303	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—glaucoma	3.32e-05	0.000302	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.3e-05	0.0003	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAV1—glaucoma	3.29e-05	0.000299	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCA1—glaucoma	3.26e-05	0.000297	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1B1—glaucoma	3.26e-05	0.000297	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—glaucoma	3.2e-05	0.000291	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—glaucoma	2.87e-05	0.000261	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCA1—glaucoma	2.84e-05	0.000258	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1B1—glaucoma	2.84e-05	0.000258	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.69e-05	0.000244	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCA1—glaucoma	2.65e-05	0.000241	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1B1—glaucoma	2.65e-05	0.000241	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—glaucoma	2.61e-05	0.000237	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—glaucoma	2.49e-05	0.000226	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—glaucoma	2.3e-05	0.000209	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—glaucoma	2.28e-05	0.000207	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—glaucoma	2.27e-05	0.000207	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—glaucoma	2.17e-05	0.000197	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—glaucoma	2.14e-05	0.000195	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAV1—glaucoma	2.13e-05	0.000193	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—glaucoma	2.12e-05	0.000193	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—glaucoma	2.01e-05	0.000183	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—glaucoma	1.88e-05	0.000171	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—glaucoma	1.87e-05	0.00017	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAV1—glaucoma	1.85e-05	0.000168	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—glaucoma	1.75e-05	0.000159	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAV1—glaucoma	1.73e-05	0.000157	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—glaucoma	1.61e-05	0.000146	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—glaucoma	1.47e-05	0.000134	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—glaucoma	1.4e-05	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—glaucoma	1.31e-05	0.000119	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—glaucoma	1.28e-05	0.000116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—glaucoma	1.2e-05	0.000109	CbGpPWpGaD
